You are here:Home-Chemical Inhibitors & Agonists-Antibiotics and Antivirals-HSV-FV-100
FV-100

Chemical Structure : FV-100

CAS No.: 956483-03-7

FV-100 (Valnivudine;FV100;CF-1743)

Catalog No.: PC-63468Not For Human Use, Lab Use Only.

FV-100 (Valnivudine, CF-1743) is a potent, selective, bicyclic nucleoside analogue inhibitor of varicella zoster virus (VZV) with EC50 of subnanomolar range in vitro..

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

FV-100 (Valnivudine, CF-1743) is a potent, selective, bicyclic nucleoside analogue inhibitor of varicella zoster virus (VZV) with EC50 of subnanomolar range in vitro.

HSV Infection

Phase 3 Clinical

Physicochemical Properties

M.Wt 548.077
Formula C28H38ClN3O6
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

((2R,3S,5R)-3-hydroxy-5-(2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3(2H)-yl)tetrahydrofuran-2-yl)methyl (S)-3-amino-4-methylpentanoate hydrochloride

References

1. McGuigan C, et al. J Antimicrob Chemother. 2007 Dec;60(6):1316-30.

2. Pentikis HS, et al. Antimicrob Agents Chemother. 2011 Jun;55(6):2847-54.

3. Migliore M. Antivir Chem Chemother. 2010 Jan 5;20(3):107-15.

4. Tyring SK, et al. J Med Virol. 2017 Jul;89(7):1255-1264.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: